Skip to content

Author

D. Wrześniok

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Novel Lomefloxacin–Triazole Hybrids: Design, Synthesis and In Vitro Antiproliferative Activity in Breast, Melanoma and Colon Cancer Cell Lines

In recent years, extensive research has focused on fluoroquinolone–triazole hybrids, with particular emphasis on structural modifications of ciprofloxacin. In the present study, novel derivatives of lomefloxacin with a 1,4-disubstituted-1,2,3-triazole moiety were designed, synthesised, and biologically evaluated at the...

Justyna Nowakowska, Zuzanna Rzepka, A. Bąk et al. · 0 citations
Review Open access Jul 2026

Autophagy in Melanoma: Molecular Mechanisms and Therapeutic Perspectives

Melanoma is a malignant tumor that originates in pigment-producing cells called melanocytes. This type of cancer remains a major public health challenge due to its high metastatic potential and resistance to treatment. Autophagy is a catabolic process that enables the controlled degradation of damaged cellular organell...

Dominika Stencel, D. Wrześniok · 0 citations
Jul 2026

Mechanistic insights into EB171 anticancer activity in MCF7 and MDA-MB-231 breast cancer cells showing differential responses.

Breast cancer remains one of the leading causes of cancer-related mortality in women worldwide, with estrogen receptor α (ERα) signaling playing a key role in hormone-dependent tumors. Here, we investigated the molecular basis of the anticancer activity of EB171, an amide derivative of betulonic acid, in breast cancer...

Zuzanna Rzepka, Dominika Stencel, E. Bębenek et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.